PepFold

Gene Database

COMTCatechol-O-Methyltransferase

Chromosome 22q11.21

Degrades catecholamines (dopamine, epinephrine, norepinephrine) in the prefrontal cortex. The Val/Met polymorphism creates a spectrum of dopamine metabolism rates affecting cognition, pain, and stress response.

Pharmacogenomic Variants

Peptide Therapeutic Approaches

COMT-stabilizing peptides for the Met allele, allosteric modulators for activity normalization, and genotype-informed analgesic peptide design.

Related Therapeutics

Entacapone (COMT inhibitor)Morphine (affected by COMT status)

Associated Conditions

Analyze COMT variants with PepFold

Submit rs4680 and get ranked peptide candidates in under 2 minutes.